These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. APOE ε4 and Memory Among Patients With Heart Failure. Pressler SJ; Harrison JM; Titler M; Koelling TM; Jung M; Dorsey SG; Bakoyannis G; Riley PL; Hoyland-Domenico L; Giordani B West J Nurs Res; 2017 Apr; 39(4):455-472. PubMed ID: 27733670 [TBL] [Abstract][Full Text] [Related]
6. Variations in the APOE allele or BDNF Val66Met polymorphism are not associated with changes in cognitive function following a tertiary education intervention in older adults: the Tasmanian Healthy Brain Project. Thow ME; Summers MJ; Summers JJ; Saunders NL; Vickers JC Neurobiol Aging; 2017 Jul; 55():175-176. PubMed ID: 28438485 [TBL] [Abstract][Full Text] [Related]
7. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment. Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052 [TBL] [Abstract][Full Text] [Related]
8. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease. Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE; Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413 [TBL] [Abstract][Full Text] [Related]
9. Evaluating depressive symptoms, BDNF Val66Met, and APOE-ε4 as moderators of response to computerized cognitive training in heart failure. Pressler SJ; Jung M; Giordani B; Titler MG; Gradus-Pizlo I; Lake KR; Wierenga KL; Clark DG; Perkins SM; Smith DG; Mocci E; Dorsey SG Heart Lung; 2023; 59():146-156. PubMed ID: 36805256 [TBL] [Abstract][Full Text] [Related]
10. Beneficial Effect of Societal Factors on APOE-ε2 and ε4 Carriers' Brain Health: A Systematic Review. Aravena JM; Lee J; Schwartz AE; Nyhan K; Wang SY; Levy BR J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37792627 [TBL] [Abstract][Full Text] [Related]
11. APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults. Ward DD; Summers MJ; Saunders NL; Janssen P; Stuart KE; Vickers JC Behav Brain Res; 2014 Sep; 271():309-15. PubMed ID: 24946073 [TBL] [Abstract][Full Text] [Related]
12. Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia. Tsai SJ; Gau YT; Liu ME; Hsieh CH; Liou YJ; Hong CJ Neurosci Lett; 2008 Mar; 433(2):158-62. PubMed ID: 18242855 [TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270 [TBL] [Abstract][Full Text] [Related]
14. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623 [TBL] [Abstract][Full Text] [Related]
15. Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M; Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706 [TBL] [Abstract][Full Text] [Related]
16. APOEε4 impacts up-regulation of brain-derived neurotrophic factor after a six-month stretch and aerobic exercise intervention in mild cognitively impaired elderly African Americans: A pilot study. Allard JS; Ntekim O; Johnson SP; Ngwa JS; Bond V; Pinder D; Gillum RF; Fungwe TV; Kwagyan J; Obisesan TO Exp Gerontol; 2017 Jan; 87(Pt A):129-136. PubMed ID: 27864047 [TBL] [Abstract][Full Text] [Related]
17. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment. Insel PS; Hansson O; Mattsson-Carlgren N JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis. Chen Q; Wang T; Kang D; Chen L Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759 [TBL] [Abstract][Full Text] [Related]
19. Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease. Liu YH; Jiao SS; Wang YR; Bu XL; Yao XQ; Xiang Y; Wang QH; Wang L; Deng J; Li J; Zhou XF; Zhou HD; Wang YJ Mol Neurobiol; 2015; 51(3):1271-7. PubMed ID: 24986007 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]